Clinical Trials Browser

Phase 2 × Prostate Cancer Metastatic × Docetaxel × Clear all

NCT04028388 2024-04-17

ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer

Phase 2 Completed

135 enrolled 29 charts

Prostate Cancer Metastatic

NCT04603833 2021-02-21

A Study of SHR3680 in Combination With Docetaxel in the Treatment of mCRPC

Phase 2 Unknown

Prostate Cancer Metastatic

NCT01718353 2017-11-20

TAXYNERGY

Phase 2 Completed

63 enrolled 13 charts

Prostate Cancer Metastatic